Skip to main content

MARSHALL WACE, LLP

Position in LQDA — Liquidia Corp

CIK 1318757 LONDON, X0

Position in LQDA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$10,923,427
+$5,900,338 QoQ
Shares Held
289,439
+98.7% QoQ
Ownership
0.325%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
10 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in LQDA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. LQDA ranks #15 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LQDA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,923,427 289,439
2025-12-31 $5,023,089 145,639
2025-09-30 $7,556,251 332,289
2025-06-30 $8,233,093 660,762
2025-03-31 $6,143,773 416,527
2024-12-31 $3,366,756 286,289
2024-09-30 $1,486,960 148,696
2024-06-30 $545,448 45,454
2022-09-30 $249,228 45,814
2021-03-31 $33,006 12,270